StockData
BioNexus Gene Lab Corp logo

BioNexus Gene Lab Corp (BGLC) stock

BGLCNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 8/3090% below fair value
$0.77−0.05 (-6.56%)

Close on Nov 17, 2026Market cap $2.25MP/E –Yield –

BioNexus Gene Lab market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

BioNexus Gene Lab's market cap was $2.08M on Nov 11, 2026, against $8.16M a year earlier. Over the last 5 years it ranged from $2.08M to $43.77B, with a median of $86.17M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.08M-70.7%
2025Dec 31, 2025$7.10M-85.9%
2024Dec 31, 2024$50.26M-46.7%
2023Dec 29, 2023$94.30M-99.5%
2022Dec 30, 2022$19.80B-54.7%
2021Dec 31, 2021$43.77B+54.3%
2020Dec 31, 2020$28.35B–

More BioNexus Gene Lab figures

See a number that looks wrong?